CYP2A6 and lung carcinoma: Cytochrome P450 2A6 (CYP2A6) is known to metabolize nicotine, the major constituent of tobacco, leading to the production of toxic metabolites and induction of oxidative stress that result in tissue damage and disease progression such as liver damage and lung cancer, respectively1.